Epidemiology of varicella hospitalizations in the United States, 1995-2005

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Reynolds, Meredith A ^a,f   Watson, Barbara M ^b   Plott Adams, Kelly K ^a,c   Jumaan, Aisha O ^a   Galil, Karin ^a,e   Maupin, Teresa J ^d   Zhang, John X ^a   Seward, Jane F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^e Idenix Pharmaceuticals Inc   (United States)

^f NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ATAXIA; BLEEDING TENDENCY; CELLULITIS; CHICKENPOX; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; ENCEPHALITIS; FEMALE; HEALTH PROGRAM; HEALTH STATUS; HIGH RISK POPULATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMPETIGO; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; SKIN ABSCESS; UNITED STATES; VACCINATION;

ADOLESCENT; ADULT; CALIFORNIA; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; PENNSYLVANIA; POPULATION SURVEILLANCE; RISK FACTORS; TEXAS; UNITED STATES; VACCINATION;

EID: 42549152880     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522146     Document Type: Conference Paper

References (27)

1. Galil K, Brown C, Lin F, Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J 2002; 21:931-5.
2. Jackson MA, Burry VF, Olson LC. Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 1992; 11:441-5.
3. Choo PW, Donahue JG, Manson JE, Platt R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172:706-12.
4. Ratner AJ. Varicella-related hospitalizations in the vaccine period. Pediatr Infect Dis J 2002; 21:927-31.
5. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114:786-92.
6. Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis 2000; 182:383-90.
7. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80:465-72.
8. Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986; 78:757-62.
9. Gershon A, Takahashi M, Seward J. Varicella vaccine. In: Plotkin ST, Orenstein WA, eds. Vaccines. Philadelphia: Elsevier, 2004:783-824.
10. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996; 10:571-81.
11. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 2005; 352:450-8.
12. Staat MA, Meinzen-Derr J, Welch T, et al. Varicella-related hospitalization and emergency department visit rates, before and after introduction of varicella vaccine, among white and black children in Hamilton County, Ohio. Pediatrics 2006; 117:e833-9.
13. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002; 287:606-11.
14. Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005; 294:797-802.
15. Ratner AJ. Varicella-related hospitalizations: an update. Pediatr Infect Dis J 2004; 23:377.
16. Centers for Disease Control and Prevention. Outbreak of invasive group A Streptococcus associated with varicella in a childcare center - Boston, Massachusetts, 1997. MMWR Morb Mortal Wkly Rep 1997; 46:944-8.
17. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in southern California. Pediatr Infect Dis J 1996; 15:146-50.
18. Council of State and Territorial Epidemiologists (CSTE). CSTE position statement 1999-ID9: vaccine preventable disease surveillance and reporting. Available at: http://www.cste.org/ps/1999/1999-id-09.htm. Accessed 31 August 2006.
19. Watson B, Keller PM, Ellis RW, Starr SE. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J Infect Dis 1990; 162:794-9.
20. Diaz PS, Smith S, Hunter E, Arvin AM. Immunity to whole varicellazoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. J Infect Dis 1988; 158:1245-52.
21. Merck & Co, Inc. VARIVAX [Varicella virus vaccine live (Oka/Merck)] prescribing information. Whitehouse Station, NJ: Merck & Co, 2006.
22. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996; 45(RR-11):1-36.
23. Luman ET, Ching PL, Jumaan AO, Seward JF. Uptake of varicella vaccination among young children in the United States: a success story in eliminating racial and ethnic disparities. Pediatrics 2006; 117:999-1008.
24. Seward J, Jumaan A. VZV: persistence in the population: transmission and epidemiology. In: Arvin A, ed. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge, UK: Cambridge University Press, 2007:713-35.
25. Yawn BP, Yawn RA, Lydick E. Community impact of childhood varicella infections. J Pediatr 1997; 130:759-65.
26. Seward JF, Marin M, Vázquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis 2008; 197(Suppl 2):S82-9 (in this supplement).
27. Marin M, Guris D, Chaves SS, Schmid S, Seward JF. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56(RR-4):1-40.